Answers are grounded in this paper and cite their sources.
Cost-effectiveness analysis shows potential benefits of rapid testing for UTIs in Japan, suggesting wider usage.
Compared with the broad-spectrum antibiotic agents plus culture strategy, which is common practice in Japan, the POCT strategy demonstrated potential cost-effectiveness for patients with cystitis and pyelonephritis. These results suggest that introducing POCTs for patients with UTIs in Japan may be a cost-effective approach.
No takes yet. Share an insight, caveat, or question.
Niiro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: